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Abstract
Background: Acute Stanford type A aortic dissection (TAAD) is a life-threatening condition. Surgery is usually
performed as a salvage procedure and is associated with significant postoperative early mortality and morbidity.
Understanding the patient’s conditions and treatment strategies which are associated with these adverse events is
essential for an appropriate management of acute TAAD.
Methods: Nineteen centers of cardiac surgery from seven European countries have collaborated to create a
multicentre observational registry (ERTAAD), which will enroll consecutive patients who underwent surgery for acute
TAAD from January 2005 to March 2021. Analysis of the impact of patient’s comorbidities, conditions at referral, surgical
strategies and perioperative treatment on the early and late adverse events will be performed. The investigators have
developed a classification of the urgency of the procedure based on the severity of preoperative hemodynamic
conditions and malperfusion secondary to acute TAAD. The primary clinical outcomes will be in-hospital mortality, late
mortality and reoperations on the aorta. Secondary outcomes will be stroke, acute kidney injury, surgical site infection,
reoperation for bleeding, blood transfusion and length of stay in the intensive care unit.
Discussion: The analysis of this multicentre registry will allow conclusive results on the prognostic importance of
critical preoperative conditions and the value of different treatment strategies to reduce the risk of early adverse events
after surgery for acute TAAD. This registry is expected to provide insights into the long-term durability of different
strategies of surgical repair for TAAD.
Trial registration: ClinicalTrials.gov Identifier: NCT04831073.
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Background
Acute Stanford type A aortic dissection (TAAD) is a
life-threatening condition. Surgery is usually performed
as a salvage procedure and is associated with increased
postoperative early mortality and morbidity [1]. Al-
though early mortality has declined during the last years
[2], the recent The Nordic Consortium for Acute Type
A Aortic Dissection registry including 1189 patients op-
erated from 2005 to 2015 in 8 centers showed that 30-
day mortality after surgery for acute TAAD was as high
as 18% [3]. The multicentre, prospective German Regis-
try for Acute Aortic Dissection type A including 2137
TAAD patients operated from 2006 and 2010 docu-
mented a 30-day mortality of 16.9% [4]. A more recent
analysis of the Society of Thoracic Surgeon database in-
cluding 7353 patients operated from 2014 and 2017 for
acute TAAD reported a 30-day mortality of 17% [5].
Furthermore, surgery for TAAD is often complicated by
major adverse events such as stroke [5] and acute kidney
failure [6], which may have a significant impact on late
survival. In this scenario of significant postoperative
mortality and morbidity, surgeon faces the controversial
issue of the extent of surgical repair for acute TAAD by
avoiding a major surgical repair, which may increase the
risk of early adverse events, and by resecting segments of
the aorta which otherwise may expose the patient to the
risk of late aortic-related complications [7, 8]. Under-
standing the balance between the patient’s conditions
which may not allow extensive procedure and those
treatment strategies which may limit the risk of late ad-
verse events in patients who remain alive long after the
surgery is essential for an appropriate management of
TAAD. However, previous registries [1, 3] did not pro-
vide information on the long-term durability of these
procedures. We have planned the multicenter European
registry of surgery for acute TAAD (ERTAAD) to evalu-
ate the contemporary early outcomes and the durability
of different surgical strategies for acute TAAD at 15
years in a large study population.
Methods
The ERTAAD is an observational registry including pa-
tients who underwent surgery for acute TAAD at 19
centers of cardiac surgery located in seven (eight, if you
allow adding two coauthors) European countries
(Belgium, Czech Republic, Finland, France, Germany,
Italy, Spain and the United Kingdom) (Table 1) from
January 1, 2005 to March 31, 2021. Data will be retro-
spectively collected on patients treated during the study
period and the aim is to gather further data for future
clinical research on this topic. Data on consecutive pa-
tients with acute TAAD will be collected into a Micro-
soft Access datasheet (Redmond, Washington, USA)
with pre-specified baseline, operative and outcome
variables. Permission to conduct this study will be re-
quested from institutional or national review boards ac-
cording to local legislation.
Inclusion criteria
– TAAD or intramural hematoma involving the
ascending aorta;
– Patients aged > 18 years:
– Symptoms started within 7 days from surgery;
– Primary surgical repair of acute TAAD;
– Any other major cardiac surgical procedure
concomitant with surgery for TAAD.
Exclusion criteria
– Patients aged < 18 years;
– Onset of symptoms > 7 days from surgery;
– Prior procedure for TAAD;
– Retrograde TAAD (with primary tear located in the
descending aorta);
– Concomitant endocarditis;
– TAAD secondary to blunt or penetrating chest
trauma.
Table 1 Participating centers
Participating centers
1. Ziekenhuis Oost-Limburg, Genk, Belgium
2. Saint-Luc’s Hospital, Brussels, Belgium
3. Sint-Jan Hospital, Bruges, Belgium
4. Antwerp University Hospital, Edegem, Belgium
5. University Hospitals Leuven, Leuven, Belgium
6. Institute of Clinical and Experimental Medicine, Prague, Czech
Republic
7. Helsinki University Hospital, Helsinki, Finland
8. Jean Minjoz University Hospital, Besançon, France
9. Hôpital Henri Mondor, Assistance Publique - Hôpitaux de Paris, Créteil,
France
10. Leipzig Heart Center, Leipzig, Germany
11. University Heart and Vascular Centre Hamburg, Hamburg, Germany
12. Münster University Hospital, Münster, Germany
13. University of Turin, Turin, Italy
14. University of Verona Medical School, Verona, Italy
15. University of Udine, Udine, Italy
16. Glenfield Hospital, University Hospitals of Leicester, Leicester, UK
17. Liverpool Heart and Chest Hospital, Liverpool, UK
18. Sheffield Teaching Hospital, Sheffield, UK
19. Southampton University Hospital, Southampton, UK
20. Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain
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Clinical and operative variables and their
definition criteria
Individual surgeon’s experience
Surgeon having performed performing at least 20 elect-
ive or urgent procedures on the ascending aorta/aortic
arch in the preceding year.
Baseline and postoperative laboratory parameters
Baseline levels of hemoglobin, creatinine, platelets, arter-
ial lactate, cardiac enzymes and C-reactive protein as
well as postoperative lowest levels of hemoglobin and
platelets and postoperative peak levels of creatinine and
arterial lactate will be collected.
Preoperative antithrombotic drugs
Exposure to any of the following antithrombotic drugs
within 2 days before surgery: aspirin, clopidogrel, ticagre-
lor, prasugrel, ticlopidine, low-molecular weight heparin,
unfractionated heparin, fondaparinux, direct oral antico-
agulants and/or warfarin.
Renal function
Renal function will be classified according to the esti-
mated glomerular filtration rate (eGFR) calculated using
the Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) equation [9] and the European Kidney Func-
tion Consortium (EKFC) equation [10]. The severity of
renal failure will be classified in different stages as listed
in Table 2.
Genetic syndromes
Genetic syndromes may lead to aortopathies and TAAD
[11]. Information on any specific genetic syndrome asso-
ciated with TAAD will be collected in this registry.
Arterial hypertension
Systemic arterial pressure > 150/80 mmHg or use of anti-
hypertensive drugs.
Diabetes
Hyperglycemia requiring treatment with insulin or oral
drugs.
Prior stroke
Any preoperative focal or global neurological syndrome
caused by ischemia or hemorrhage not resolving within
24 h. It refers to a neurological event occurring any time
before hospitalization for TAAD, but not to a neuro-
logical event related to acute TAAD.
Prior transient ischemic attack
Any preoperative focal or global neurological syndrome
caused by ischemia or hemorrhage resolving within 24 h.
It refers to a neurological event occurring any time be-
fore hospitalization for TAAD, but not to a neurological
event related to acute TAAD.
Pulmonary disease
Use of bronchodilators and/or steroids for lung dis-
eases [12].
Extracardiac arteriopathy
One or more of the following: lower limb claudication,
critical limb ischemia, carotid occlusion or > 50% sten-
osis, major amputation for arterial disease, previous or
planned intervention on the abdominal aorta or on the
extremities or carotid arteries [12].
Poor mobility
Severe impairment of mobility due to musculoskeletal or
neurological dysfunction [12].
Moderate-to-severe frailty
Patient needs assistance because of moderate-to-severe
physical and cognitive impairment (score > 5 on the
Rockwood Clinical Frailty Scale) [13].
New York Heart Association functional classes
Functional classes according to the New York Heart As-
sociation classification whose definition criteria are sum-
marized in Table 3 [14].
Recent myocardial infarction
Myocardial infarction within 90 days from the index sur-
gery [12]. It includes acute coronary malperfusion (i.e.
any changes in ST level in electrocardiogram and/or an
increase in cardiac enzymes).
Pulmonary hypertension
Systolic pulmonary artery pressure on arrival in the op-
erating room classified in three categories: < 31 mmHg,
31–55mmHg and > 55mmHg [12].
Critical preoperative state
Ventricular tachycardia or ventricular fibrillation or
aborted sudden death, preoperative cardiac massage,
preoperative ventilation before anesthetic room,







5 < 15 or dialysis
eGFR estimated glomerular filtration rate
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preoperative inotropes, preoperative acute renal failure
(anuria or oliguria < 10 ml/hr) [12]. These conditions
will be reported as separate variables.
Urgency of the procedure
Urgency of the procedure will be classified in five cat-
egories based on increasing severity of hemodynamic in-
stability and the need and timing of cardiopulmonary
resuscitation (Table 4).
Urgent procedure refers to a procedure which was
scheduled for the next working day from admission or
later during the index hospitalization. These patients
were hemodynamically stable and paucisymptomatic. In
these patients, TAAD was considered not to cause to
malperfusion and/or aortic rupture within the next few
hours/days.
Emergency grade 1 refers to any procedure which was
performed before the beginning of the next working day
in symptomatic or paucisymptomatic patients with
stable hemodynamic conditions and without signs of
malperfusion. The procedure was performed within a
few hours after admission to the hospital.
Emergency grade 2 refers to any procedure which was
performed before the beginning of the next working day
because of hemodynamic instability despite the use of
inotropes and/or of malperfusion. These patients did not
require cardiopulmonary resuscitation. The procedure
was performed immediately after admission to the hos-
pital or worsening of the patients’ conditions.
Salvage grade 1 refers to any procedure which was
performed in patients requiring cardiopulmonary
resuscitation with external chest compressions and/or
open cardiac massage between induction of anesthesia
and initiation of cardiopulmonary bypass. The procedure
was performed when the conditions of the patients
worsened after induction anesthesia due to acute heart
failure, cardiac tamponade and/or frank rupture of the
aorta. These patients required either external chest com-
pressions before sternotomy and/or cardiac massage
after sternotomy and prompt initiation of cardiopulmo-
nary bypass.
Salvage grade 2 refers to any procedure which was
performed in patients requiring cardiopulmonary resus-
citation with external chest compressions en route to
the operating theatre or prior to induction of anesthesia.
These patients might have required also cardiac massage
after sternotomy and prompt initiation of cardiopulmo-
nary bypass. In these patients, the operation was per-
formed on compassionate basis without knowledge of
frank rupture of the aorta or severe end-organ injury.
Neurological status immediately before procedure
Unconsciousness before sedation, hemiplegia/hemipar-
esis, paraplegia/paraparesis, dysarthria/aphasia, vision
loss, confusion, or intubated/sedated at arrival. These
conditions will be reported as separate variables.
Malperfusion
Malperfusion refers to acute organ ischemia secondary
to aortic branch vessel hypoperfusion. This severe condi-
tion is usually classified based on clinical signs and
symptoms [15, 16]. Herein, myocardial malperfusion will
Table 3 New York Heart Association functional classes
Class Patient symptoms
I No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea, or anginal pain.
II Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea or anginal pain.
III Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea or anginal pain.
IV Inability to carry on any physical activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest.
If any physical activity is undertaken, discomfort is increased.
Table 4 Urgency of the procedure.*
Urgency Definition
Urgent Scheduled procedure performed in paucisymptomatic patients with stable hemodynamic conditions during the index
hospitalization since the next working day from admission
Emergency
grade 1
Procedure performed in patients with stable conditions and without malperfusion before the beginning of the next working day
Emergency
grade 2
Procedure performed in patients with hemodynamic instability despite the use of inotropes and/or any malperfusion before the
beginning of the next working day - no cardiopulmonary resuscitation with chest compression required
Salvage grade 1 Procedure performed in patients requiring cardiopulmonary resuscitation with external chest compressions and/or open chest
cardiac massage between induction of anesthesia and initiation of cardiopulmonary bypass
Salvage grade 2 Procedure performed in patients requiring cardiopulmonary resuscitation with external chest compressions en route to the
operating theatre or before induction of anesthesia
Further details on the definition criteria of the urgency of the procedure are reported in the text
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be defined as any changes in ST level in electrocardio-
gram and/or an increase in cardiac enzymes. Cerebral
malperfusion will be defined as acute preoperative
stroke. Spinal malperfusion will be defined as acute para-
paresis/paraplegia. Mesenteric malperfusion will be as
sudden, mild-to-severe abdominal pain with or without
nausea and vomiting, which is accompanied or not by
rectal bleeding or bloody diarrhea [17]. Renal malperfu-
sion will be defined as anuria/oliguria. Peripheral mal-
perfusion will be defined as loss of pulse with or without
sensory or motor deficits of any limb.
Preoperative computed tomography findings
Preoperative computed tomography scans will be
reviewed for evaluation of the extent of aortic dissec-
tion/intramural hematoma in different segments of the
aorta and its branches. Dissection of the aortic branches
will be defined as any intimal flap at the origin of the ar-
tery causing stenosis of any severity. This applies also to
aortic branches perfused through the false lumen.
Data on maximal diameter of the aortic root, ascend-
ing aorta, aortic arch, descending aorta and abdominal
aorta will be collected.
Intramural hematoma
A contained aortic wall hematoma within the media, but
without intimal flap formation of the ascending aorta.
Patients will be considered as having aortic intramural
hematoma when no concomitant aortic intimal flap was
observed at preoperative aortic imaging. When intra-
mural hematoma was associated with an intimal flap of
any other segment of the aorta, this will be classified as
a true aortic dissection.
Heart valve status and left ventricular function
Data from preoperative echocardiographic evaluation of
the aortic valve, mitral valve and left ventricular function
will be collected.
Arterial and venous cannulation sites
It refers to the primary cannulation sites. Any switch to
other cannulation site before initiation of cardioplegia
will be described.
Intraoperative findings
Data on the intraoperative findings of the pericardium,
ascending aorta and aortic arch will be collected. The
extent of aortic dissection at the level of the Valsalva si-
nuses and morphology of the aortic valve will be
described.
Surgical repair
Data on the type of aortic root/ascending aorta and aor-
tic arch surgical repair will be collected along with data
on any concomitant major cardiac surgery procedure.
Details regarding the level of aortic anastomosis will be
documented. In particular, data on aortic anastomosis
suture techniques (i.e. the use and number of layers of
Teflon or pericardial patch to reinforce the anastomosis
and the aortic wall) and the use of biological glue to the
dissected tissues will be retrieved. Double layer
reinforcement patch technique refers to an anastomosis
suture with a combination of one patch outside the aorta
and the other between the dissected tissues or from in-
side the aorta. Triple layer reinforcement patch tech-
nique refers to an anastomosis suture with a
combination of one patch outside the aorta, one within
the dissected tissues and one from inside the aorta.
Cardiopulmonary bypass parameters
Data on duration of myocardial ischemia, cardiopulmo-
nary bypass, hypothermic circulatory arrest and retro-
grade or antegrade cerebral perfusion will be collected.
When multiple periods of perfusion or organ ischemia
have occurred, the total length of these periods will be
reported. The lowest temperature during hypothermic
circulatory arrest will be documented.
Outcomes and their definition criteria
Hospital death
All-cause death having occurred during the index
hospitalization, i.e. at the institution where surgery for
TAAD was performed.
Acute heart failure
Postoperative heart failure requiring prolonged use of
inotropes (> 24 h) and/or the insertion of any mechanical
circulatory support device.
Stroke
Acute episode of a focal or global neurological deficit
with at least one of the following: change in the level of
consciousness, hemiplegia, hemiparesis, numbness, or
sensory loss affecting one side of the body, dysphasia or
aphasia, hemianopia, amaurosis fugax, or other neuro-
logical signs or symptoms consistent with stroke dur-
ation of a focal or global neurological deficit ≥24 h;
OR < 24 h if available neuroimaging documents a new
brain hemorrhage or infarct; OR the neurological deficit
results in death [18]. Stroke will be classified as ischemic,
hemorrhagic or both.
Global brain ischemia
Diffuse hypoxic damage as diagnosed at brain imaging
and electroencephalography.
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Paraplegia/paraparesis
Bilateral weakness and/or multimodality sensory disturb-
ance below the level of the ischemic spinal lesion.
Mesenteric ischemia
Abdominal pain with or without nausea and vomiting
and rectal bleeding or bloody diarrhea [17]. Diagnosis is
done at imaging, endoscopy and/or surgery.
Acute kidney injury
It will be defined according to postoperative change in
serum creatinine levels and its severity will be stratified
according to the Kidney Disease: Improving Global Out-
comes (KDIGO) criteria [19] (Table 5). However, in view
of the prolonged hospital treatment of TAAD patients,
changes in serum creatinine level will be evaluated as oc-
curring during the entire index hospitalization. We
recognize that acute kidney injury can also be diagnosed
according to urine output measure. However, this
method is not feasible in retrospectively gathered data
and therefore it will not be considered in the present
study. Dialysis will be defined as temporary when dis-
continued and permanent if continued at the time of
discharge from the institution where surgery for acute
TAAD was performed.
Perioperative bleeding
Data on number of transfused units of red blood cell will
be collected. The E-CABG bleeding classification has
been proposed as a simple classification of perioperative
bleeding [20] and it has been shown being comparable
to the Universal Definition of Perioperative Bleeding
[21] in predicting early mortality [22]. Herein we will
adopt a simplified version of the E-CABG perioperative
classification. This classification defines severe bleeding
as transfusion of more than 4 units of red blood cells
during and after surgery and/or reoperation for excessive
intrathoracic bleeding (Table 6).
Reoperation for bleeding
Chest reopening for excessive bleeding. It qualifies as a
reoperation for bleeding also any reoperation for
excessive bleeding in patients in whom the sternum was
left open. Chest reopening for hemodynamic instability
without excessive bleeding as well as pericardial/pleural
puncture or chest drain insertion for retained blood syn-
drome do not qualify as reoperations for bleeding.
Deep sternal wound infection/mediastinitis
Proven infection involving deep sternal wound tissues
and/or mediastinum.
Procedures for vascular complications
Any vascular and endovascular procedure for ischemic
or bleeding complications.
These complications will encompass neurologic com-
plications, mesenteric ischemia, upper and lower limb is-
chemia as well as bleeding from the aorta and its
branches.
Mechanical circulatory support
The use of intra-aortic balloon pump and/or venoarterial
extracorporeal membrane oxygenation for postoperative
acute heart failure. The duration of treatment of these
salvage therapies will be documented.
Length of stay in the intensive care unit
Overall length of treatment in the intensive care unit, in-
cluding readmissions, at the institution where surgery
for TAAD was performed.
Late outcomes
Data on patient’s survival status will be collected. Pa-
tients lost to follow-up will be reported.
Data on any repeat surgical or endovascular procedure
on the aorta will be reported along with its urgency, in-
dications and aortic segment treated.
Sample size calculation
The impact of total aortic arch repair compared to more
limited aortic resection on the early and late outcomes
will be one of the main topics of research from this
registry. Therefore, in the light of the expected limited
frequency of this surgical strategy, we performed a sam-
ple size analysis considering the extent of distal aortic
Table 5 Definition criteria of postoperative acute kidney injury.a
Stages Serum creatinine
1 1.5–1.9 times baseline
OR
≥0.3 mg/dL (≥26.5 micromol/L) increase
2 2–2.9 times baseline
3 ≥3.0 times baseline
OR
Increase to ≥4 mg/dL (≥353.6 micromol/L)
OR
Initiation of renal replacement therapy
aChanges in serum creatinine level occurring during the index hospitalization
Table 6 Simplified E-CABG perioperative bleeding classification
[20]
Grades Intervention for treatment of bleeding
0 No RBC transfusion or transfusion of 1 unit of RBCs
1 Transfusion of 2–4 units of RBCs
2 Transfusion of 5–10 units of RBCs
and/or
reoperation for intrathoracic bleeding
3 Transfusion of > 10 units of RBCs
RBC red blood cell
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resection. Despite the limitation of a pooled analysis
which did not take in to account the cumulative inci-
dences from competing risk analysis and the segment of
repeat operation, Poon et al. [23] estimated a pooled
hazard ratio on 0.73 (95%CI 0.56–1.18) of freedom from
any late aortic reoperation for total arch replacement.
Based on this hazard ratio, a sample size of 163 patients
per study groups would be enough to reject the null hy-
pothesis (alpha 0.05, power 0.80). Pan et al. [24] reported
a freedom from distal reoperation after ascending aortic
resection at 8 years of 95.3% which was not statistically
different from that of hemiarch or total aortic arch re-
pair (92.4%, p = 0.22). For the sample size calculation of
a non-inferiority trial, we assumed a freedom rate from
distal aortic reoperation of 95% and we considered that
a difference in the reoperation rate as large as 10% in
favor of a total aortic arch repair still allow the less ex-
tensive repair to be non-inferior (delta = 0.1, power 0.90,
one-sided confidence 97.5%), the required sample size
would be 100 patients per each group. We assume that
about 5% of patients have undergone total arch repair in
this collaborative registry and therefore a study popula-
tion of 4000 patients would be enough to investigate the
impact of total aortic arch repair in preventing late aor-
tic reoperation in patients with acute TAAD. The par-
ticipating hospitals are expected to provide a sample size
of more than 6000 patients (i.e. at least a mean of > 20
procedures for acute TAAD each year), which would
prevent a type II error.
Statistical analysis
Statistical analyses will be conducted using Stata v. 15.1
(StataCorp LLC, Texas, USA) and SPSS v. 27.0 (IBM
Corporation, Armonk, NY, USA) statistical softwares.
Continuous variables and outcomes will be reported as
mean and standard deviation as well as median and
interquartile range. Categorical variables and outcomes
will be reported as counts and percentages. A p < 0.05
will be set for statistical significance. Differences be-
tween the study groups will be evaluated using the Fish-
er’s exact test, the Chi-square test, the linear-by-linear
association test, the Mann-Whitney test and the
Kruskall-Wallis test. The McNemar test and paired sam-
ples T-test will be used in the paired groups. Propensity
score matching will be performed to balance treatment
strategies for baseline differences. A propensity score
will be estimated using a non-parsimonious multilevel
mixed-effects logistic regression considering the cluster
effect of the participating centers whose results may be
affected by the referral pathway, surgical techniques and
perioperative care. Multilevel mixed-effects logistic re-
gression model will include all available baseline vari-
ables. The estimated propensity score will be employed
for inverse propensity score weighting analysis and one-
to-one propensity score matching analysis using a caliper
width of 0.1 to 0.2 of the standard deviation of the esti-
mated logit. Standardized differences < 0.10 will be con-
sidered an acceptable imbalance between the matched
cohorts.
Survival analysis will be performed using the Kaplan-
Meier method with the log-rank test and the Cox pro-
portional hazards method. Competing risk analysis with
the Gray’s test will be performed for late non-fatal ad-
verse events because patient’s death might hinder the
observation of these events. Regression models will in-
clude covariates with p < 0.05 or p < 0.2 in univariate
analysis according to the number of covariates of inter-
est. Risk estimates will reported as hazard ratios and
subdistribution hazard ratios with their 95% confidence
intervals.
Logistic and linear regression analyses will be
employed to identify independent risk factors for early
adverse events with and without a stepwise approach.
For the purpose of developing a risk scoring method
from this registry, the study cohort will be randomly di-
vided into two datasets, i.e. the derivation data set
(75.0% of patients) and the validation data set (25.0% of
patients). Univariate analysis will be performed on all
candidate covariates of the derivation dataset to identify
predictors of in-hospital mortality. Multiple logistic re-
gression analysis will be then performed using the deriv-
ation dataset. A stepwise procedure with a bootstrap
approach will be used, and 100 samples will be extracted
with a size of 70% of the derivation dataset. A stepwise
procedure will be applied to each sample (probability to
stay = 0.05; probability to entry = 0.1). Variables selected
in at least 50% of the stepwise procedures will be in-
cluded in the regression model. Additional covariates
were selected using a forward selection comparing the
Akaike information criterion for the models with and
without each covariate. The model with the lowest
Akaike information criterion will be selected for each
forward step, until the inclusion of a new covariate de-
termined an increase in the Akaike information criterion
value. The model will be tested in the validation data set
for calibration, using the Hosmer–Lemeshow test, and
for discrimination using the receiver-operating charac-
teristic curve analysis. A comparison of the predictive
ability of the new score with the current risk scoring
methods for prediction of in-hospital mortality will be
performed in the overall dataset as well as in the valid-
ation dataset using the DeLong test. The improvement
of discrimination of the new score will be estimated by
calculating the net reclassification index and the inte-
grated discrimination improvement. Finally, to evaluate
the adaptability of the new score for prediction of late
mortality, Kaplan–Meier curves stratified by deciles of
the new score will be plotted.
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Interinstitutional and between-surgeons differences in
terms of early outcomes will be evaluated using mixed-
effects logistic regression. The risk-adjusted rate of ad-
verse binary events at each center will estimated by div-
iding the observed number of adverse events by the
expected number of adverse events, and by multiplying
this ratio by the average event rate of the overall series.
The expected numbers of adverse events will be calcu-
lated with logistic regression. The estimated risk-
adjusted rates of adverse events will be summarized as
odds ratios and their 95% confidence intervals in cater-
pillar plots with the x-axis ordered for increasing ad-
justed rates.
Discussion
Implications for the treatment of TAAD patients
Analysis of the data from this collaborative registry will
allow analysis of contemporary results of a large number
of TAAD patients with a rather long follow-up period.
We expect that the multicentre nature of this registry
will allow reduction in the risk of bias related to institu-
tional volume and surgical experience. In fact, all the
participating centers have an annually rate of at least 25
procedures for acute TAAD and have an aortic surgery
program which would facilitate an adequate follow-up
and management of possible late aortic events after pri-
mary repair of TAAD. Therefore, we expect to gather
data which will provide important insights into the as-
sessment of the operative risk of patients with acute
TAAD and conclusive results on the value of different
surgical and perfusion strategies for this emergency
condition.Limitations
The retrospective nature is the main limitation of this
registry. However, our aim is to investigate the out-
come at 15 years of these patients, and this may not
be feasible with a prospective registry. Second, the
prognostic impact of different treatment strategies will
be analyzed using several statistical methods to adjust
for baseline differences. However, the lack of
randomization does not prevent the effects of con-
founding variables. Third, perioperative care may sig-
nificantly vary between institutions as well as
individual surgeons and their effects should be con-
sidered in all analyses.
Strengths
This registry will include detailed data on patients’
characteristics, operative strategies and outcomes from
centers with large volume of cardiac surgery and sig-
nificant experience in the treatment of acute and
chronic aortic diseases. This may reduce the risk of
bias related to limited experience in the surgical
treatment of aortic diseases. This multicenter registry
will allow recruiting of more than 6000 patients,
which is expected to decrease the risk of type II er-
rors. The long follow-up of this study will allow reli-
able analysis of the durability of different surgical
repair strategies.
Conclusions
The ERTAAD is expected to recruit a large number of
patients who underwent surgery for acute TAAD. This
multicenter study will allow the identification of risk fac-
tors associated with major adverse events and of strat-
egies for adequate end-organ protection. The rather long
follow-up of this registry is expected to provide solid
data on the durability of different types of aortic repair
strategies.
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